70

Elena V Svirshchevskaya1, Valentina V Kostenko1, Anna A Boyko1

  • 1Laboratory of Cell Interactions, Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, Russia.

PubMed
概括

研究人员使用单克隆抗体开发了针对性抗癌纳米颗粒,用于对抗细胞膜暴露的热冲击蛋白70kDa (mHSP70). 这些针对mHSP70的纳米颗粒显示出针对瘤细胞提供抗癌药物的前景.